Search is Powered by Google
Cancer / Oncology News

BMI predicts breast cancer survival

Main Category: Cancer / Oncology
Article Date: 31 May 2004 - 9:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:5 stars

5 (1 votes)

Article Opinions: 0 posts

Increasing body mass index (BMI) is a negative prognostic indicator for women undergoing surgery for breast cancer, research by the International Breast Cancer Study Group (IBCSG) suggests. Gilles Berclaz (Institute of Medical Oncology, Inselspital, Bern, Switzerland) and colleagues reviewed data from 6792 participants in IBCSG chemotherapy and endocrine therapy trials between 1978 and1993.

The team investigated the relationship between patient outcome and BMI, menopausal status, nodal involvement, estrogen and progesterone receptor status, treatment, and tumor size, vessel invasion, and grade.

As reported in the Annals of Oncology, when BMI was assessed as a global univariate prognostic factor, women with a normal BMI achieved significantly longer overall and disease-free survival than overweight or obese women. After taking into account the other risk factors, BMI remained a significant predictive factor for overall but not disease-free survival.

To continue reading this article please go to the following web page of http://hcp.breastcancersource.com




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

customize your homepage

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...